Star Polymers As Novel Antimicrobial And Immunomodulatory Agents
Funder
National Health and Medical Research Council
Funding Amount
$945,908.00
Summary
The rise in antibiotic resistance in bacteria is considered as a major public health threat that is not being met by antibiotic research. This project will modify a novel star polymer that we have shown kills antibiotic resistant bacteria but does not induce resistance. The project will make and characterise new versions of the star polymer to produce antimicrobial materials that target and kill the multi-drug resistant bacteria that are a major cause of bacterial infections and death.
Improving Bionic Device Safety And Performance With Conductive Hydrogels
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
Bionic devices are being developed to treat a variety of neural disorders including blindness. Conductive hydrogels (CHs) are a new soft material developed by the CI to improve device performance and safety. This project will explore CH technologies with an aim of producing flexible organic electronics for high resolution devices, such as the bionic eye. Collaboration will be sought through industry, academia and clinical researchers to accelerate technology translation from bench to bedside.
Ocular Implant For The Treatment Of Bacterial Endophthalmitis
Funder
National Health and Medical Research Council
Funding Amount
$483,446.00
Summary
We seek to develop an ocular implant for the treatment of bacterial endophthalmitis. The implant will be a small device that can be administered directly to the affected ocular cavity to release an antibiotic in a controlled manner to clear any infection. The implant will erode and leave no residue. It will be produced from a novel drug-polymer conjugate technology that allows polymer devices that comprise >50% drug to be made.
Enhanced And Highly Specific Delivery Of Small Interfering RNA And Oligonucleotides As Therapeutics For Gene Silencing
Funder
National Health and Medical Research Council
Funding Amount
$311,860.00
Summary
This proposal aims to develop glyco-nanocarriers for the efficient and specific delivery of siRNA/oligonucleotides to treat liver diseases. Complex glycopolymer architectures developed here will protect desired genes from enzymatic degradation and will deliver the gene to the liver specifically for therapy, hence providing a solution towards nucleic acid therapy.
Sequence-defined polymers and green chemistry. This project aims to synthesise polymers that have precise chemical structure and mimic the biological activities of natural biopolymers like peptides and proteins. Monomer sequence regulation in these natural biopolymers is important in biology and necessary for crucial features of life, such as molecular recognition, self-replication and catalysis. Current artificial techniques for biopolymer synthesis are time consuming and present low yields at ....Sequence-defined polymers and green chemistry. This project aims to synthesise polymers that have precise chemical structure and mimic the biological activities of natural biopolymers like peptides and proteins. Monomer sequence regulation in these natural biopolymers is important in biology and necessary for crucial features of life, such as molecular recognition, self-replication and catalysis. Current artificial techniques for biopolymer synthesis are time consuming and present low yields at high costs. This project expects its new materials will increase manufacturing sustainability, chemical diversity and industrial viability; produce health benefits for Australia by improving chemotherapy and diagnosis for diseases; and benefit the Australian economy.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE110100028
Funder
Australian Research Council
Funding Amount
$720,000.00
Summary
Ultra-high resolution and advanced analytical scanning electron microscope facility. This scanning electron microscope facility will form an essential part of characterising a broad range of material types, from nanometre sized particles through to cells and their interactions.